4 free views remaining today
obsolete Hepeviridae infectious disease
ICD-10 Codes
Related ICD-10:
Description
Hepatitis E Virus (HEV) Disease Description
The hepatitis E virus (HEV) was previously considered a disease of the developing world, but it is now recognized as a significant global public health concern. HEV is one of the leading causes of acute viral hepatitis worldwide.
- Transmission: The transmission of HEV mainly occurs via the fecal-oral route (ingesting contaminated food or water).
- Symptoms: The prodrome and clinical symptoms are indistinguishable from other forms of hepatitis, including:
- Nausea
- Fever
- Vomiting
- Abdominal pain
- Anorexia
- Fatigue
- Global Impact: HEV is estimated to cause 20 million infections and up to 70,000 deaths annually worldwide.
- Neurological Manifestation: Research indicates that neurological manifestation of HEV is a rare but still underestimated course of disease, occurring at any age and gender.
HEV was previously classified as an obsolete Hepeviridae infectious disease, but it remains a significant public health concern today. [1][2][3][4][5]
Additional Characteristics
- Vomiting
- Anorexia
- Nausea
- Fever
- Fatigue
- Abdominal pain
- fecal-oral route
Signs and Symptoms
Based on the provided context, it appears that there are no search results related to signs and symptoms of an obsolete Hepeviridae infectious disease.
However, I can provide information on Hepatitis E virus (HEV), which is a member of the Hepeviridae family. According
Additional Symptoms
Diagnostic Tests
Based on the provided context, it appears that there are several diagnostic tests available for detecting infections caused by the Hepeviridae family, which includes hepatitis E virus (HEV).
Diagnostic Testing
According to search result [1], diagnostic testing should include both anti-HEV-IgM (and anti-HEV-IgG) and HEV-RNA in serum or stool. This is also supported by search result [4], which states that diagnostic testing should include both anti-HEV-IgM (and anti-HEV-IgG) and HEV-RNA in serum or stool.
Specific Laboratory Tests
Search result [3] mentions specific laboratory tests like the classical HEV IgM/IgG antibodies, HEV RNA, and the recently developed novel HEV Ag, and IgG avidity based methods. These tests can aid in diagnosis of HEV infections.
Stool Tests and Serological Analysis
Search result [2] notes that stool tests and serological analysis aid in diagnosis. A liver biopsy demonstrates periportal fibrosis, indicating liver damage due to the infection.
Other Diagnostic Methods
Search result [10] mentions that direct molecular assays are needed to detect HEV infection, as antibody tests can be unreliable. This highlights the importance of using multiple diagnostic methods to confirm a diagnosis.
In summary, diagnostic testing for obsolete Hepeviridae infectious diseases involves a combination of anti-HEV-IgM and IgG antibodies, HEV-RNA detection in serum or stool, and specific laboratory tests such as classical HEV IgM/IgG antibodies and novel HEV Ag. Stool tests and serological analysis can also aid in diagnosis.
References: [1] M Wiesenfarth · 2024 · Cited by 5 [2] U Shah · Cited by 1 [3] P Pankovics · 2020 · Cited by 12 [4] M Wiesenfarth · 2024 · Cited by 5 [10] JH Hoofnagle · 2012 · Cited by 669
Additional Diagnostic Tests
- anti-HEV-IgM and anti-HEV-IgG
- HEV-RNA in serum or stool
- IgG antibodies
- HEV RNA
- novel HEV Ag
- novel HEV IgG avidity based methods
- stool tests
- serological analysis
Treatment
Based on the provided context, it appears that you are looking for information on the drug treatment of an outdated Hepatitis B infection.
Current Treatment Options
According to search result [3], currently, six medications are available for HBV (Hepatitis B Virus) treatment, including interferon and five nucleoside/nucleotide analogues. These medications have been the treatment of choice for chronic hepatitis B during the last decades.
First-Line Treatment Options
Search result [7] mentions that Entecavir and tenofovir are first-line treatment options for oral antiviral therapy in patients with HBV infection. Pegylated interferon is an alternative option
Recommended Medications
- Tenofovir
- Pegylated Interferon
- entecavir
- entecavir (anhydrous)
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Differential Diagnosis of Hepatitis E Virus (HEV) Infection
Hepatitis E virus (HEV) infection, previously classified under the family Hepeviridae, is a viral hepatitis caused by a RNA virus. When encountering patients with symptoms of viral hepatitis, it's essential to consider HEV infection in the differential diagnosis, especially if serologic markers for other forms of hepatitis are negative.
Differential Diagnosis Considerations
- Liver Injury during Peritoneal Dialysis (PD): In patients developing liver injury during PD, HEV infection should be included in the differential diagnosis [2][4].
- Acute and Self-Limiting Hepatitis: HEV infections have diverse clinical manifestations, including acute and self-limiting hepatitis, acute-on-chronic liver disease, chronic hepatitis, cirrhosis, and more [1][5].
- Negative Serologic Markers: In cases where serologic markers for other forms of hepatitis are negative, HEV infection should be considered in the differential diagnosis [3].
Other Conditions to Consider
- Mild Acute Cellular Rejection: This condition can present with similar symptoms and may require differentiation from HEV infection.
- Drug-Induced Liver Injury: Certain medications, such as ezetimibe and alfuzosin, can cause liver injury that may be mistaken for HEV infection [8].
Quality of Guidelines
Recent studies have aimed to systematically assess the quality of guidelines for diagnosing and treating HEV infection, highlighting the need for standardized approaches and updated recommendations [9].
References:
[1] Aslan AT (2020) - Cited by 177 [2] Yan T (2022) - Cited by 2 [3] Diagnosis and Treatment (no author) [4] Yan T (2022) - Cited by 2 [5] Aslan AT (2020) - Cited by 177 [6] Bricks G (2019) - Cited by 19 [7] Wiesenfarth M (2024) - Cited by 5 [8] Lee GH (2016) - Cited by 615 [9] Gu T (2024)
Additional Differential Diagnoses
- Liver Injury during Peritoneal Dialysis (PD)
- Acute and Self-Limiting Hepatitis
- Negative Serologic Markers
- Mild Acute Cellular Rejection
- Drug-Induced Liver Injury
Additional Information
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#id
- DOID:0050219
- core#notation
- DOID:0050219
- IAO_0000115
- A (+)ssRNA virus infectious disease that results_in infection in animals and humans, located_in liver, has_material_basis_in Hepeviridae viruses.
- rdf-schema#label
- obsolete Hepeviridae infectious disease
- owl#deprecated
- true
- relatedICD
- http://example.org/icd10/K76.81
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_273
- owl#annotatedSource
- t327630
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.